Review Article
The Effect of Immunosuppressive Drugs on MDSCs in Transplantation
Table 1
MDSCs in transplantation.
| Species | Years | Graft type | MDSC location | Functional subsets | In vitro assay | Immune modulation | Mechanism of action | Ref. |
| Human | 2018 | Intestine | PBMC, intestinal mucosa | PMN-MDSC, M-MDSC, e-MDSC | Anti-CD3/28/MLR | Tac + P/HC + (MMF) | — | [28] | Human | 2014 | Kidney | PBMC | Total | No | Tac(CsA) + P + (MMF) | — | [27] | Human | 2013 | Kidney | PBMC | M-MDSC, e-MDSC | MLR | Tac + P + MMF | — | [46] | Human | 2015 | Allo-HSCT | WBC | M-MDSC, PMN-MDSC | Anti-CD3/28 | Tac + methotrexate | iNOS/Arg1 | [48] | Human | 2015 | Haplo-identical allo-HSCT | WBC | M-MDSC, PMN-MDSC, e-MDSC | — | CsA + MTX + MMF | — | [49] | Human | 2013 | Allo-HSCT | PBMC | M-MDSC | Anti-CD2/CD3/CD28-stimulating bead | Tac(CsA) + MTX | IDO | [46] | Mouse | 2003 | BMT | Spleen | Total | MLR | Irradiation | iNOS | [50] | Mouse | 2004 | BMT | Spleen | Total | MLR | Irradiation SHIP KO | — | [54] | Mouse | 2011 2012 | Parental splenocyte to F1 | Spleen | M-MDSC, PMN-MDSC | OT1 splenocytes with OVA/MLR | — | iNOS | [59] [60] | Mouse | 2018 | Heart | Spleen | M-MDSC | Anti-CD3/28 | Dex | iNOS | [90] | Mouse | 2015 | Heart | Graft | CD11b+CD115+Ly6Clo, Ly6G−CD169+ | MLR | Anti-CD40L | IL-10 | [42] | Mouse | 2010 | Heart | Graft | M-MDSC | Anti-CD3/28 | Anti-CD40L + DST | iNOS | [25] | Mouse | 2015 | Heart | Spleen | M-MDSC, PMN-MDSC | Anti-CD3/28 | Rapa | iNOS | [30] | Mouse | 2016 | Skin | Spleen | M-MDSC (inhibition by rapa) | Anti-CD3/28 | Rapa | iNOS | [29] | Mouse | 2016 | Skin | Spleen | Total | Anti-CD3/28 | CsA | iNOS | [103] | Mouse | 2014 | Skin | Spleen | Total | MLR | Dex | iNOS | [89] | Mouse | 2014 | Skin | Spleen | Total | MLR | CsA | IDO | [102] | Mouse | 2012 | Heart | Graft | CD11b+IDO+ | — | ECDI-fixed donor splenocyte + (rapa) | IDO | [44] | Rat | 2008 | Kidney | Blood | CD6−NKRP-1+CD80/86+ | MLR | Anti-CD28 | iNOS | [31] | Mouse | 2011 | Heart | Graft | M-MDSC | No | IL-33 | — | [36] | Mouse | 2012 | Skin | Spleen | Total | MLR | Smad3-KO | iNOS | [34] | Mouse | 2008 | Skin | Spleen | Total | Anti-CD3/28 | ILT2-TG | Arg1 | [33] |
|
|
TAC: tacrolimus; CsA: cyclosporin A; P: prednisolone/prednisone; HC: hydrocortisone; MMF: mycophenolate mofetil; MTX: methotrexate; MP: methylprednisolone.
|